BFEC
ONCS

Benjamin F. Edwards & Company’s OncoSec Medical Incorporated ONCS Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45
Closed -$1K – 1935
2022
Q1 		$1K Hold
45
– – ﹤0.01% 1751
2021
Q4 		$1K Hold
45
– – ﹤0.01% 1693
2021
Q3 		$2K Buy
+45
New +$2.28K ﹤0.01% 1658

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Benjamin F. Edwards & Company's ONCS Position: Q2 2022 in Review

Benjamin F. Edwards & Company sold out of OncoSec Medical Incorporated (ONCS) in Q2 2022, closing a stake of 45 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in ONCS in Q3 2021 and held it in 3 quarters. The position peaked at $2K in Q3 2021. 25 funds tracked by Wall St. Rank hold ONCS as of Q2 2022.

  • Benjamin F. Edwards & Company reported no remaining OncoSec Medical Incorporated position as of Q2 2022 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 45 OncoSec Medical Incorporated shares in Q2 2022, an estimated $1K.
  • Benjamin F. Edwards & Company first reported a position in OncoSec Medical Incorporated in Q3 2021 and held it in 3 quarters.
  • Benjamin F. Edwards & Company's OncoSec Medical Incorporated position peaked at $2K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2022.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2022, filed 12 Aug 2022.